Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase

NCT00327262 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
240
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Central European Leukemia Study Group